Literature DB >> 6442196

Monitoring the treatment of Paget's disease with etidronate.

J A Kanis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6442196     DOI: 10.1007/bf02405380

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


× No keyword cloud information.
  17 in total

1.  Diphosphonates and inhibition of bone mineralization.

Authors:  C Nagant de Deuxchaisnes; C Rombouts-Lindemans; J P Huaux; J P Devogelaer
Journal:  Lancet       Date:  1982-09-11       Impact factor: 79.321

2.  Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).

Authors:  R D Altman; C C Johnston; M R Khairi; H Wellman; A N Serafini; R R Sankey
Journal:  N Engl J Med       Date:  1973-12-27       Impact factor: 91.245

3.  The treatment of Paget's bone disease with sodium ethidronate.

Authors:  G A Fromm; F Schajowicz; C Casco; G Ghiringhelli; C A Mautalen
Journal:  Am J Med Sci       Date:  1979 Jan-Feb       Impact factor: 2.378

4.  [Clinical, biological and histological effects of ethane-1-hydroxy 1, 1-diphosphonate (EDHP) in Paget's disease].

Authors:  P Meunier; M C Chapuy; P Courpron; E Vignon; C Edouard; J Bernard
Journal:  Rev Rhum Mal Osteoartic       Date:  1975-11

5.  Diphosphonate treatment of Paget's disease.

Authors:  G A Finerman; H C Gonick; R K Smith; J M Mayfield
Journal:  Clin Orthop Relat Res       Date:  1976-10       Impact factor: 4.176

6.  Changes in the renal and extrarenal handling of phosphate induced by disodium etidronate (EHDP) in man.

Authors:  R J Walton; R G Russell; R Smith
Journal:  Clin Sci Mol Med       Date:  1975-07

Review 7.  Calcitonin and diphosphonate in the treatment of Paget's disease of bone.

Authors:  D J Hosking
Journal:  Metab Bone Dis Relat Res       Date:  1981

8.  Effects of ethane-1 hydroxy-1, 1-diphosphonate (5 mg/kg/day dose) on quantitative bone histology in Paget's disease of bone.

Authors:  C Alexandre; P J Meunier; C Edouard; R A Khairi; C C Johnston
Journal:  Metab Bone Dis Relat Res       Date:  1981

9.  Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP).

Authors:  C C Johnston; R D Altman; R E Canfield; G A Finerman; J D Taulbee; M L Ebert
Journal:  Clin Orthop Relat Res       Date:  1983 Jan-Feb       Impact factor: 4.176

10.  Use of etidronate (EHDP) in Paget's disease of bone.

Authors:  C C Johnston; M R Khairi; P J Meunier
Journal:  Arthritis Rheum       Date:  1980-10
View more
  4 in total

Review 1.  Treating Paget's disease.

Authors:  D A Heath
Journal:  Br Med J (Clin Res Ed)       Date:  1987-04-25

2.  Effective short term treatment of Paget's disease with oral etidronate.

Authors:  C J Preston; A J Yates; M N Beneton; R G Russell; R E Gray; R Smith; J A Kanis
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-11

3.  Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate.

Authors:  S Adami; G Salvagno; G Guarrera; F Montesanti; S Garavelli; S Rosini; V Lo Cascio
Journal:  Calcif Tissue Int       Date:  1986-10       Impact factor: 4.333

4.  Treatment of malignant hypercalcaemia with clodronate.

Authors:  R C Percival; A D Paterson; A J Yates; D J Beard; D L Douglas; F E Neal; R G Russell; J A Kanis
Journal:  Br J Cancer       Date:  1985-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.